مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

18
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

22
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Vinpocetine’, s immunomodulating, anti-oxidant, anti-inflammatory, ant-ifibrotic, and PDE inhibiting potencies ameliorate bleomycin-induced pulmonary fibrosis

Pages

  13-22

Abstract

 Objective(s): Pulmonary fibrosis (PF) is a global health problem with a high economic burden. Intratracheal administration of bleomycin is the best model that resembles the pathogenesis of PF in humans. Recently, Vinpocetine proved to have neuroprotective, cardioprotective, hepatoprotective, anti-aging, and Antifibrotic effects through its Anti-oxidant, immunomodulating, and Anti-inflammatory activities. The present study investigated the Antifibrotic potentiality of Vinpocetine in a rat model of PF induced by intratracheal bleomycin administration. Materials and Methods: PF induced by a single intratracheal instillation of 5 mg/kg bleomycin in nine-week-old Wister rats. Oral Vinpocetine was used at doses of 5, 10, or 20 mg/kg to treat PF for 21 days immediately after the bleomycin instillation. Results: Vinpocetine dose-dependently ameliorates PF induced by bleomycin administration since Vinpocetine effectively restored the normal body weight gain rates, pulmonary architecture, and collagen fiber distribution and suppressed the elevated BALF cell count, lymphocytes and neutrophils percentage, BALF, IL-6, TNF-α, , and TGF-β, 1 levels and LDH activity, lung tissue MDA level, PDE activity, hydroxyproline content, immunohistochemical expression of α,-SMA and CD68 positive macrophage, and fibrosis score. Meanwhile, it efficiently augmented the reduced BALF macrophage percentage, IL-10 level, lung tissue GSH level, CAT, and SOD activities. Conclusion: Vinpocetine may propose a new promising agent to manage PF.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    Balaha, Mohamed, Alahmari, Abdullah, Kandeel, Samah, & Balaha, Marwa. (2023). Vinpocetine’, s immunomodulating, anti-oxidant, anti-inflammatory, ant-ifibrotic, and PDE inhibiting potencies ameliorate bleomycin-induced pulmonary fibrosis. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 26(1), 13-22. SID. https://sid.ir/paper/1084895/en

    Vancouver: Copy

    Balaha Mohamed, Alahmari Abdullah, Kandeel Samah, Balaha Marwa. Vinpocetine’, s immunomodulating, anti-oxidant, anti-inflammatory, ant-ifibrotic, and PDE inhibiting potencies ameliorate bleomycin-induced pulmonary fibrosis. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES[Internet]. 2023;26(1):13-22. Available from: https://sid.ir/paper/1084895/en

    IEEE: Copy

    Mohamed Balaha, Abdullah Alahmari, Samah Kandeel, and Marwa Balaha, “Vinpocetine’, s immunomodulating, anti-oxidant, anti-inflammatory, ant-ifibrotic, and PDE inhibiting potencies ameliorate bleomycin-induced pulmonary fibrosis,” IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, vol. 26, no. 1, pp. 13–22, 2023, [Online]. Available: https://sid.ir/paper/1084895/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button